BioHealth News Archive
National View: Not college for all, but college for more
In a recent op-ed column headlined "The failure of college for all" (May 28), Robert J. Samuelson raised some interesting ideas, such as enhanced…
Read More
CMS ANNOUNCES PRIVATE-SECTOR COMMITMENTS TO IMPROVE PRIMARY CARE FOR PATIENTS, SAVE MONEY FOR MEDICARE
In a strong show of support for more effective, more affordable, higher quality health care, 45 commercial, federal and State insurers in seven markets…
Read More
NCI: SBIR & STTR – Resource Center – Innovative Partnerships for Commercializing Health IT
The National Cancer Institute (NCI) recently announced a new Program Announcement, aimed at accelerating the development and commercialization of consumer health information technology products…
Read More
PhaseBio Pharmaceuticals Closes $48.4M Series B -peHUB
PhaseBio Pharmaceuticals Inc., a clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, has closed its Series B round with…
Read More
Maryland entrepreneurs urge culture change – MDBIZNews
A panel of entrepreneurs told the Maryland Economic Development Commission on Tuesday that Maryland needs to commercialize more discoveries made in academic and government…
Read More
Shady Grove Office Center lands Tech Council of Maryland headquarters – Washington Business Journal
The Tech Council of Maryland has moved into its new headquarters in the Shady Grove Office Center, Citybizlist.com reports. The new location, at 9210…
Read More
HHS harnesses the power of health data to improve health
The Department of Health and Human Services (HHS), along with the Institute of Medicine (IoM) and other members of the Health Data Consortium, are…
Read More
Tech Council of Maryland Moves Headquarters to New Rockville Office
The Tech Council of Maryland (TCM), Maryland's largest technology trade association with more than 400 biotechnology and technology members employing more than 200,000 in…
Read More
Morning Read: VC sees opportunities in areas where Pharma is pulling back
Counter-intuitive as it may be, investing in areas that pharma is abandoning could yield great returns for investors. Just look at anti-bacterials in the…
Read More
Maryland’s 18 Most Promising Incubator Companies – Citybizlist Baltimore
The 12th Annual Maryland Incubator Company of the Year Awards, supported by the Maryland Department of Business and Economic Development (DBED), the Maryland Technology…
Read More
UMBC Incubator Gets New Cyber Security Firms
The incubator at University of Maryland, Baltimore County has gotten an influx of new tenants, the majority of whom are responding to the increased demand for cyber security. bwtech@UMBC Research…
Read More
Immunomic Therapeutics’ CEO, Dr. William G. Hearl, to Present at 2012 BIO International in June
Immunomic Therapeutics, Inc., ("ITI") a privately-held biotechnology company with laboratories in Rockville, MD, announced that it has been accepted to present at the Business…
Read More
Immunomic Therapeutics Receives IND Authorization from FDA for Phase I Study of Japanese Red Cedar LAMP-vax Vaccine
Immunomic Therapeutics, Inc., ("ITI," Lancaster, PA) a privately-held biotechnology company with laboratories in Rockville, MD, announced that the U.S. Food and Drug Administration (FDA)…
Read More
Merck Looks to Startups – Technology Review
With pharmaceutical industry research budgets shrinking, large drug companies are instead looking to support early-stage biotechnology startups. Merck, Eli Lilly, and GlaxoSmithKline have all…
Read More
Cultural competency: A communication challenge for all | Washington Times Communities
Thousands upon thousands of brilliant, motivated, hard working—and legal—immigrants live in the United States. Every year additional highly educated professionals arrive to study and…
Read More